Oppenheimer Reiterates Outperform Rating on Amgen (AMGN), remains well-positioned across various Horizon (HZNP) scenarios
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| Amgen Inc (NASDAQ: AMGN) | Delayed: 466.01 +5.28 (1.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $460.73 | 52 Week High | $176.85 | |||
| Open | $470.15 | 52 Week Low | $133.64 | |||
| Day High | $475.65 | P/E | 70.18 | |||
| Day Low | $465.33 | EPS | $6.64 | |||
| Volume | 3,290,610 | |||||
| HORIZON PHARMA (NASDAQ: HZNP) | Delayed: 116.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $116.30 | 52 Week High | $23.44 | |||
| Open | $19.84 | 52 Week Low | $13.06 | |||
| Day High | $116.30 | P/E | N/A | |||
| Day Low | $116.30 | EPS | $-0.96 | |||
| Volume | 283,408 | |||||
